Cholera Oral Vaccine from Germany
Inactivated oral vaccine with recombinant B-subunit and killed whole cells for cholera prevention in travelers. HTS 3002.49.0050 applies as an 'other' microbial culture-based vaccine for prophylactic human use. Not yeast-derived, fitting chapter exclusions.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• File FDA prior notice 72 hours pre-arrival; ensure tamper-evident packaging for oral suspension
• Provide WHO prequalification if available; document GMO status for biotech-derived components